Senior insider sale
CHIEF EXECUTIVE OFFICER at CUE BIOPHARMA, INC. — senior position signals high conviction
$1.60M
58.26K shares
What this filing means
LIN SHAO-LEE plans to sell 58.26K shares of CUE BIOPHARMA, INC. valued at approximately $1.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2026ACC: 0001725092-26-000011
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2026
58.26K
Shares to sell
$1.60M
Approx. market value
58.26K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under registered plan
Compensation
8/1/2026
58.26KTotal acquired58.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/1/2026 | Restricted Stock Units vesting under registered plan Compensation | 58.26K | — |
| Total | 58.26K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
18.26K
Market value
$516.0K
8/13/2026
NASDAQPlanned
Units to sell
40K
Market value
$1.08M
8/12/2026
Total
Units
58.26K
Value
$1.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 18.26K | $516.0K | NASDAQ | Planned |
8/12/2026 | 40K | $1.08M | NASDAQ | Planned |
| Total | 58.26K | $1.60M | ||